| abstract |
The invention provides compounds for the treatment and/or prevention of influenza. The compound comprises a first domain and a second domain, wherein the first domain comprises at least one anchor group that binds to a surface of an influenza virus, and the second domain comprises at least one anionic group. The first domain is covalently linked to the second domain. The invention also provides pharmaceutically acceptable salts, solvates, prodrugs or stereoisomers of such compounds. |